JPMorgan Chase & Co’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-1
| Closed | – | – | 6483 |
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6394 |
|
2022
Q4 | $0 | Sell |
1
-2
| -67% | – | ﹤0.01% | 6220 |
|
2022
Q3 | $0 | Sell |
3
-12
| -80% | – | ﹤0.01% | 6053 |
|
2022
Q2 | $0 | Sell |
15
-829
| -98% | – | ﹤0.01% | 6138 |
|
2022
Q1 | $10K | Sell |
844
-1,215
| -59% | -$14.4K | ﹤0.01% | 5400 |
|
2021
Q4 | $33K | Sell |
2,059
-11,639
| -85% | -$187K | ﹤0.01% | 5208 |
|
2021
Q3 | $331K | Sell |
13,698
-3,481
| -20% | -$84.1K | ﹤0.01% | 4171 |
|
2021
Q2 | $599K | Sell |
17,179
-90
| -0.5% | -$3.14K | ﹤0.01% | 3898 |
|
2021
Q1 | $831K | Buy |
17,269
+8,073
| +88% | +$388K | ﹤0.01% | 3766 |
|
2020
Q4 | $446K | Buy |
9,196
+7,142
| +348% | +$346K | ﹤0.01% | 3809 |
|
2020
Q3 | $71K | Buy |
2,054
+595
| +41% | +$20.6K | ﹤0.01% | 4190 |
|
2020
Q2 | $101K | Sell |
1,459
-6,424
| -81% | -$445K | ﹤0.01% | 3968 |
|
2020
Q1 | $188K | Buy |
+7,883
| New | +$188K | ﹤0.01% | 3727 |
|
2019
Q3 | – | Sell |
-25
| Closed | – | – | 4974 |
|
2019
Q2 | $0 | Sell |
25
-19,967
| -100% | – | ﹤0.01% | 4999 |
|
2019
Q1 | $276K | Sell |
19,992
-4,972
| -20% | -$68.6K | ﹤0.01% | 3624 |
|
2018
Q4 | $204K | Buy |
24,964
+24,648
| +7,800% | +$201K | ﹤0.01% | 3803 |
|
2018
Q3 | $7K | Buy |
316
+39
| +14% | +$864 | ﹤0.01% | 4688 |
|
2018
Q2 | $14K | Buy |
277
+64
| +30% | +$3.24K | ﹤0.01% | 4572 |
|
2018
Q1 | $10K | Sell |
213
-446
| -68% | -$20.9K | ﹤0.01% | 4500 |
|
2017
Q4 | $30K | Buy |
+659
| New | +$30K | ﹤0.01% | 4302 |
|
2017
Q1 | – | Sell |
-768
| Closed | -$114K | – | 4577 |
|
2016
Q4 | $114K | Buy |
768
+547
| +248% | +$81.2K | ﹤0.01% | 3845 |
|
2016
Q3 | $44K | Buy |
+221
| New | +$44K | ﹤0.01% | 3627 |
|